A Study in Second Line Metastatic Colorectal Cancer

NCT01183780 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1072

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: Ramucirumab
BIOLOGICAL: Placebo
DRUG: Irinotecan
DRUG: Folinic Acid
DRUG: 5-Fluorouracil

Sponsor

Eli Lilly and Company